Literature DB >> 7914892

Interaction of gamma-glutamyl transpeptidase with acivicin.

E Stole1, T K Smith, J M Manning, A Meister.   

Abstract

Inactivation of gamma-glutamyl transpeptidase by acivicin (L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazole acetic acid) is rapid, thought to be irreversible, and associated with binding of close to 1 mol of inhibitor/mol of enzyme. Previous studies with [3-14C]acivicin indicated binding (prevented by substrate) to a specific hydroxyl group (threonine 523) of the rat kidney enzyme. In the present work, we found that such inactivation can be reversed by treating the inhibited enzyme with hydroxylamine. Reactivation (more than 85% complete) is associated with release from the inactivated enzyme of compounds that exhibit the properties of threo-beta-hydroxy-L-gamma-glutamyl hydroxamate and 3-hydroxypyrrolidone-2-carboxylate. We found that the enzyme acts very slowly on acivicin, at a rate that is about 10(-9) that of its normal catalytic rate with glutathione, to form threo-beta-hydroxy-L-glutamate and hydroxylamine. The findings indicate that inhibition by acivicin involves its transformation on the enzyme to an inhibitory species which is attached, apparently by ester linkage, to a specific hydroxyl group of the enzyme. The very slow rate of release of this intermediate appears to account for the observed inhibition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914892

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione.

Authors:  R Dringen; B Pfeiffer; B Hamprecht
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

2.  The gamma-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture.

Authors:  R Dringen; O Kranich; B Hamprecht
Journal:  Neurochem Res       Date:  1997-06       Impact factor: 3.996

3.  Divergent effects of compounds on the hydrolysis and transpeptidation reactions of γ-glutamyl transpeptidase.

Authors:  Stephanie Wickham; Nicholas Regan; Matthew B West; Vidya Prasanna Kumar; Justin Thai; Pui Kai Li; Paul F Cook; Marie H Hanigan
Journal:  J Enzyme Inhib Med Chem       Date:  2011-08-24       Impact factor: 5.051

4.  Increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [MPP(+)] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione.

Authors:  S B Foster; H Tang; K E Miller; G Dryhurst
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

5.  gamma-Glutamyl transpeptidase in the yeast Saccharomyces cerevisiae and its role in the vacuolar transport and metabolism of glutathione.

Authors:  K Mehdi; J Thierie; M J Penninckx
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

6.  Different sites of acivicin binding and inactivation of gamma-glutamyl transpeptidases.

Authors:  T K Smith; Y Ikeda; J Fujii; N Taniguchi; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

7.  The role of GSH efflux in staurosporine-induced apoptosis in colonic epithelial cells.

Authors:  Magdalena L Circu; Sarah Stringer; Carol Ann Rhoads; Mary Pat Moyer; Tak Yee Aw
Journal:  Biochem Pharmacol       Date:  2008-09-17       Impact factor: 5.858

8.  Crystal structure of acivicin-inhibited gamma-glutamyltranspeptidase reveals critical roles for its C-terminus in autoprocessing and catalysis.

Authors:  Kristin Williams; Sierra Cullati; Aaron Sand; Ekaterina I Biterova; Joseph J Barycki
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

9.  Inhibiting Glutathione Metabolism in Lung Lining Fluid as a Strategy to Augment Antioxidant Defense.

Authors:  Martin Joyce-Brady; Jun Hiratake
Journal:  Curr Enzym Inhib       Date:  2011-07

10.  Glutathione in cancer cell death.

Authors:  Angel L Ortega; Salvador Mena; Jose M Estrela
Journal:  Cancers (Basel)       Date:  2011-03-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.